Deng JL - Search Results

1

Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer.

Zhang HB, Hu Y, Deng JL, Fang GY, Zeng Y. Zhang HB, et al. Among authors: deng jl. Front Pharmacol. 2023 Sep 15;14:1243934. doi: 10.3389/fphar.2023.1243934. eCollection 2023. Front Pharmacol. 2023. PMID: 37781691 Free PMC article. Review.

2

Emerging role of long non-coding RNAs in cisplatin resistance.

Hu Y, Zhu QN, Deng JL, Li ZX, Wang G, Zhu YS. Hu Y, et al. Among authors: deng jl. Onco Targets Ther. 2018 May 28;11:3185-3194. doi: 10.2147/OTT.S158104. eCollection 2018. Onco Targets Ther. 2018. PMID: 29881292 Free PMC article. Review.

3

Effects of CORO2A on Cell Migration and Proliferation and Its Potential Regulatory Network in Breast Cancer.

Deng JL, Zhang HB, Zeng Y, Xu YH, Huang Y, Wang G. Deng JL, et al. Front Oncol. 2020 Jun 26;10:916. doi: 10.3389/fonc.2020.00916. eCollection 2020. Front Oncol. 2020. PMID: 32695665 Free PMC article.

4

Long non-coding RNA H19: a potential biomarker and therapeutic target in human malignant tumors.

Zhang R, Zeng Y, Deng JL. Zhang R, et al. Among authors: deng jl. Clin Exp Med. 2023 Sep;23(5):1425-1440. doi: 10.1007/s10238-022-00947-5. Epub 2022 Dec 9. Clin Exp Med. 2023. PMID: 36484927 Review.

5

Neurexophilin and PC-esterase domain family member 4 (NXPE4) and prostate androgen-regulated mucin-like protein 1 (PARM1) as prognostic biomarkers for colorectal cancer.

Liu YR, Hu Y, Zeng Y, Li ZX, Zhang HB, Deng JL, Wang G. Liu YR, et al. Among authors: deng jl. J Cell Biochem. 2019 Oct;120(10):18041-18052. doi: 10.1002/jcb.29107. Epub 2019 Jul 11. J Cell Biochem. 2019. PMID: 31297877

6

Polymorphisms in IGF2/H19 gene locus are associated with platinum-based chemotherapeutic response in Chinese patients with epithelial ovarian cancer.

Zeng Y, Li TL, Zhang HB, Deng JL, Zhang R, Sun H, Wan ZR, Liu YZ, Zhu YS, Wang G. Zeng Y, et al. Among authors: deng jl. Pharmacogenomics. 2019 Feb;20(3):179-188. doi: 10.2217/pgs-2018-0153. Epub 2019 Jan 23. Pharmacogenomics. 2019. PMID: 30672383

7

Identification of Candidate Genes Associated with Breast Cancer Prognosis.

Xu YH, Deng JL, Wang LP, Zhang HB, Tang L, Huang Y, Tang J, Wang SM, Wang G. Xu YH, et al. Among authors: deng jl. DNA Cell Biol. 2020 Jul;39(7):1205-1227. doi: 10.1089/dna.2020.5482. Epub 2020 May 22. DNA Cell Biol. 2020. PMID: 32456464

8

Statins induce cell apoptosis through a modulation of AKT/FOXO1 pathway in prostate cancer cells.

Deng JL, Zhang R, Zeng Y, Zhu YS, Wang G. Deng JL, et al. Cancer Manag Res. 2019 Jul 31;11:7231-7242. doi: 10.2147/CMAR.S212643. eCollection 2019. Cancer Manag Res. 2019. PMID: 31839714 Free PMC article.

9

Long non-coding RNAs in prostate cancer: Functional roles and clinical implications.

Xu YH, Deng JL, Wang G, Zhu YS. Xu YH, et al. Among authors: deng jl. Cancer Lett. 2019 Nov 1;464:37-55. doi: 10.1016/j.canlet.2019.08.010. Epub 2019 Aug 26. Cancer Lett. 2019. PMID: 31465841 Review.

10

Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis.

Deng JL, Xu YH, Wang G. Deng JL, et al. Front Genet. 2019 Aug 2;10:695. doi: 10.3389/fgene.2019.00695. eCollection 2019. Front Genet. 2019. PMID: 31428132 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters